Regeneron Pharmaceuticals, Inc

EYLEA HD

Manufacturer:

Regeneron Pharmaceuticals, Inc

Eylea Hd HCPCS:

C9161

HCPCS Code Descriptor:

Injection, aflibercept hd, 1 mg

Category:

C Code

Eylea Hd NDCs:

61755-0050-01

Primary Type:

Opthalmic

Generic/Specialty Status:

Single-Source

Route of Administration:

Intraocular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Eylea Hd:

EYLEA HD is an Opthalmic drug manufactured by Regeneron Pharmaceuticals, Inc and administered via the Intraocular route of administration. The C Code: C9161 is aligned to the drug EYLEA HD.

Eylea HD, also known as Aflibercept, is an injection for serious eye conditions, such as macular edema/degeneration, diabetic retinopathy. Eylea HD is used to preserve vision, as well as prevent blindness. Eylea HD is a growth factor inhibitor. This means the medication works by slowing the growth of abnormal blood vessels in the eye. It also can decrease leakage from these abnormal vessels.

ACCESS PRICING AND MORE BY REGISTERING

C9161 Added Date:

January 1, 2024

C9161 Effective Date:

January 1, 2024

C9161 Termination Date:

HCPCS Active

Eylea Hd billing and coding information can be found through Regeneron Pharmaceuticals, Inc at the link below:
Eylea Hd patient assistance information can be found through Eylea Patient Support at the URL: https://eyleahcp.us/s/eyleahd/eylea4u/financial-assistance
EYLEA HD prescribing information can be found at the link below:
Information regarding EYLEA HD’s side effects can be found at MedlinePlus